Patents for A61P 35 - Antineoplastic agents (221,099)
01/2007
01/24/2007CN1899607A Double effect tumor cell vaccine and its preparing method
01/24/2007CN1899604A Rectal suppository of protein medicines and its preparing method and use in systemic disease therapy
01/24/2007CN1899602A RanBPM important function in nervous system
01/24/2007CN1899585A Preparing method for Chinese herbal medicine for treating tumor
01/24/2007CN1899575A Shengxing cancer killing granular preparation
01/24/2007CN1899574A Chinese medicine composition for preventing and controlling liver cancer and its use
01/24/2007CN1899557A Chinese medicine preparation for treating leukemia
01/24/2007CN1899524A Gamboge preparation for treating various malignant tumor and its preparing process
01/24/2007CN1899517A Medicinal composition for removing chemical therapy toxic side effect and its preparing method
01/24/2007CN1899491A Method for preparing paris polyphylla total saponin and its use
01/24/2007CN1899484A Gamboge soft paste preparation and its preparing process
01/24/2007CN1899478A Chinese medicine composition for treating malignant tumor
01/24/2007CN1899473A External use Chinese herbal medicine ointment for treating mammary cancer and lymph cancer
01/24/2007CN1899463A Gamboge preparation and its preparing process
01/24/2007CN1899358A Croton alkaloid injection and its preparing method
01/24/2007CN1899352A Chinese medicine effective part composition for supplementing qi and recovering pulse
01/24/2007CN1899348A Preparation for treating esophagitis, esophagus cancer, pharyngitis and tonsillitis and its preparing method
01/24/2007CN1899343A Use of goldenrod herb oil in preparing anti-tumor medicine
01/24/2007CN1899336A Method for preparing ginseng anti-cancer active component by immobilized enzyme
01/24/2007CN1899335A Angong niuhuang soft capsule and its preparing method
01/24/2007CN1899333A Bupleurum root extract, its preparing method and its use
01/24/2007CN1899327A Radix patriniae heterophylla glucoside lipid and its preparing method
01/24/2007CN1899322A Chinese medicine preparation with organism immunity increasing function
01/24/2007CN1899320A Method for processing lucid ganoderma spore oil preparations enriched with terpenes
01/24/2007CN1899305A Chinese medicine for treating dermatosis and tumor
01/24/2007CN1899293A Use of lambda-carrageenan oligose in preparing blood vessel proliferation inhibitor
01/24/2007CN1899273A Use of Coleus forskohlii extract agent in tumor growth and preliferation inhibiting agent
01/24/2007CN1296477C Condition culture medium containing factor for inhibiting cancer cell multiplication and its preparation method
01/24/2007CN1296389C Three spiral lentinan with anti-cancer activity and its preparation and use
01/24/2007CN1296386C Use of CD 25 binding molecules in steroid-resistant patients
01/24/2007CN1296381C VEGF peptides and their use for inhibiting angiogenesis
01/24/2007CN1296377C Preparation of platinum (óÄ) complex containing ether bond carboxylic radical as ligand
01/24/2007CN1296375C Germanium caffeiate and its preparation technology
01/24/2007CN1296361C Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
01/24/2007CN1296359C Novel heteroaryl derivatives and use thereof as pharmaceuticals
01/24/2007CN1296357C Heteroaryl-substituted aminocyclohexane derivatives
01/24/2007CN1296347C Compound of antitumor antibiotic of new carbon framework as well as preparation method and application
01/24/2007CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical
01/24/2007CN1296097C Polymer micelle medicine-carrying system
01/24/2007CN1296089C Zedoary injection preparation and its preparing method
01/24/2007CN1296079C broad-spectrum oral pills for resisting and treating cancer and its preparing process
01/24/2007CN1296052C Non-injection preparation containing medium and/or low molecular weight chondroitin sulfate
01/24/2007CN1296047C Caloporoside derivatives, methods for production thereof and their use
01/24/2007CN1296043C Use of formula I Rapamycin compound in preparing pharmaceutical composition for treating solid tumor
01/24/2007CN1296039C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
01/24/2007CN1296036C Compound sophora root freeze-drying injection
01/23/2007US7167801 Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates
01/23/2007US7166744 Retinoid derivatives and methods for producing said compounds and anti-cancer pharmaceutical composition comprising said compounds
01/23/2007US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
01/23/2007US7166722 The monohydrochloric acid salt monohydrate, and its preparation by adding hydrochloric acid to a solution of N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea in an N,N-dimethylformamide or N,N-dimethylacetamide aprotic solvent, adding ethanol and ethanol and water
01/23/2007US7166719 Magnetic resonance images; tumor diagnosis; using tetrapyrrole compound
01/23/2007US7166714 Polynucleotide encoding a STEAP-1 polypeptide, used for diagnosis and treatment of prostate cancer
01/23/2007US7166707 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases
01/23/2007US7166694 Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells
01/23/2007US7166639 Blocking activation of transcription factor; aminothiophene compound; tissue repair; antiarthritic agents; inflammatory bowel disorders; antihistamines;; osteoporosis; skin disorders; autoimmune diseases
01/23/2007US7166631 E-series of prostaglandin (EP) receptors; e.g [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid
01/23/2007US7166629 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them
01/23/2007US7166628 Inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds. Ar1 is carbocycle optionally substituted with one R1, and wherein Ar1
01/23/2007US7166623 Pain and inflammation
01/23/2007US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
01/23/2007US7166617 Cyclic amide derivatives
01/23/2007US7166616 Substituted alkanoic acids
01/23/2007US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES
01/23/2007US7166605 Prophylaxis; endothelial diseases, oxidative stress, cardiovascular, inflammatory, cardiovascular, ocular, autoimmune diseases, neurological disorders and cancer, hypercholesterolemia and hyperlipidemia
01/23/2007US7166597 Antiinflammatory agents; autoimmune disease treatments; pyrazolo(1,5-a)pyridine derivatives
01/23/2007US7166592 Antiinflammatory agents
01/23/2007US7166586 Sulfonamide lactam inhibitors of FXa and method
01/23/2007US7166583 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
01/23/2007US7166467 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
01/23/2007US7166428 62112, a novel human dehydrogenase and uses thereof
01/23/2007US7166299 Comprises ursodeoxycholic acid for treating gastritis and peptic ulcer disease
01/23/2007US7166297 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen
01/23/2007US7166293 Anticancer agents; antitumor agents; cardiovascular diosrders; antiinflammatory agents
01/23/2007US7166286 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for prophylaxis and detection of cancers
01/23/2007CA2456970C Drug formulations for parenteral use
01/23/2007CA2329193C Process for synthesizing cox-2 inhibitors
01/23/2007CA2326389C Novel cd19xcd3 specific polypeptides and uses thereof
01/23/2007CA2288045C A new class of benzoporphyrin derivative photoactive compounds
01/23/2007CA2266519C Pyrimidine derivatives and processes for the preparation thereof
01/23/2007CA2245804C Recombinant ribonuclease proteins
01/23/2007CA2239968C Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells
01/23/2007CA2101104C Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumors
01/18/2007WO2007008985A2 Kinase inhibitors
01/18/2007WO2007008895A1 Kinase inhibitors
01/18/2007WO2007008664A1 3-spir0cycl0pr0pyl2-0xind0le kinase inhibitors
01/18/2007WO2007008627A2 Apoptosis promoters
01/18/2007WO2007008463A2 Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment
01/18/2007WO2007007919A2 Heterocyclic janus kinase 3 inhibitors
01/18/2007WO2007007781A1 Novel use of processed product of blueberry leaf
01/18/2007WO2007007732A1 Agent for elevating adiponectin concentration
01/18/2007WO2007007588A1 Compound having cyclic group with planarity as core
01/18/2007WO2007007524A1 Inhibitor of enzymatic activity of macrophage migration inhibitory factor
01/18/2007WO2007007317A1 Nucleic acid agents for downregulating h19, and methods of using same
01/18/2007WO2007007152A2 Anti-madcam antibodies to treat metastatic cancers and chloroma
01/18/2007WO2007007054A1 Phthalamides, succinimides and related compounds and their use as pharmaceuticals
01/18/2007WO2007006799A1 Use of sertraline in combination with an alkaloid for treating cancer
01/18/2007WO2007006797A1 Use of 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine for treating cancer
01/18/2007WO2007006700A1 Modified poly(propylene-imine) dendrimers and their use as transfection agents for anionic bioactive factors
01/18/2007WO2007006581A2 Targeting lsd1 for use in identifying and/or scoring prostate cancer and for controlling anrogen receptor-dependent gene expression
01/18/2007WO2007006547A1 Amide derivatives as kinase inhibitors